Koru Pharma is pleased to announce a strategic partnership with LYFE Capital, a global healthcare investment firm. As part of this agreement, LYFE Capital has become an important shareholder in Koru Pharma Co., Ltd., marking a significant step in the company’s international growth.
The partnership combines Koru Pharma’s expertise in regenerative aesthetics with LYFE Capital’s healthcare sector knowledge, investment experience, and global network.
With LYFE Capital’s support, Koru Pharma aims to accelerate product development, expand into new markets, and strengthen its role as a trusted partner for clinicians and distributors worldwide.
